echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > 2020 China's top 500 market capitalisation list is new, 59 pharmaceutical companies on the list (attached list)

    2020 China's top 500 market capitalisation list is new, 59 pharmaceutical companies on the list (attached list)

    • Last Update: 2020-07-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    "
    Pharmaceutical Network Market Analysis" Recently, the new 2020 issue of Chinese companies market value list of the top 500This year's list threshold reached a new high, up 2,874 million yuan from 2019, and the entry threshold reached 35.558 billion yuanIn terms of the top three on the list, Tencent topped the list with a market value of 4.35 trillion yuan, while Ali and TSMC ranked second and third with a market capitalization of 4.10 trillion yuan and 1.95 trillion yuan respectivelyby type of enterprise, Chinese companies with a market capitalization of the top 500 companies are still concentrated in the pharmaceutical and biological, financial, information technology, electronics and other industriesAmong them, the pharmaceutical biological industry, according to the author's rough statistics, a total of 59 pharmaceutical companies on the list, including Hengrui Pharmaceuticals, Murray Medical, Ali Health, Pharmaceutical Mingkang, Hanson Pharmaceuticals, Changchun High-tech, Eyre Ophthalmology, Pharmaceutical Sinbet Biology and so onchina's top 500 by market capitalisation by 2020, with 59 pharmaceutical companies listed (Source: Pharmaceutical.com)three new pharmaceutical companiesOf the 59 pharmaceutical companies, three are among the top 500 companies, namely Wantai Bio, New Industries and Legendary CreaturesAmong them, Wantai Bio is a new market capitalization record, with a total market value of 71.5 billion yuan in the top 500 ranked 256thAgainst the aura of the first domestic HPV vaccine, in the first half of 2020, Wantai Bio achieved 26 consecutive one-word ups and downs, up 1124.52%, becoming the top ten bull stocks in the first half of the yearPharmaceutical and biological industry market capitalization top10, HengRui ranked first
    the pharmaceutical and biological industry market capitalization of the top 10, HengRui with a market value of nearly 500 billion yuan in the first place, in China's top 500 companies in the market value of the top 19, market value growth rate of 26.54 percentHengrui Pharmaceuticals is a pharmaceutical and health company engaged in pharmaceutical innovation and high-quality drug research and development, production and promotion, listed on the Shanghai Stock Exchange in 2000 It ranks 13th in the Global Pharmaceutical Innovation Index, and in 2019 the company achieved revenue of 23.29 billion yuan and tax revenue of 2.43 billion yuan, and was selected as the 47th place in the TOP50 list of global pharmaceutical companies in research and development innovation, the company in recent years, the annual sales of about 15% of the research and development funds, in 2019 a cumulative investment of 3.9 billion yuan, an increase of 45.9% over the same period last year, accounting for 16.7% of sales revenue High-intensity research and development investment to the company to bring a series of major results, innovative drug injection with carellizumab, injection of toluene sulfonate rematorialen was approved for listing During the 2019 annual report period, Carilli's second-line anti-liver cancer, non-small cell lung cancer first-line, esophageal cancer second-line, and fluoropyriparic BRCA mutation ovarian cancer indications were all listed and qualified for priority review The successful renewal of the successful negotiations between the innovative drug Malaya sic ethyl tablets and thiopental injections was negotiated into the national health insurance catalogue, which will greatly reduce the burden on patients and further improve the accessibility of innovative drugs leading domestic medical equipment company, Meirui Medical, followed by a market value of 371.6 billion yuan, with a market value growth rate of 68.06 percent The company has become a multibillion-dollar medical club in less than three months In addition, Ali Health, Pharmaceutical Mingkang, Hanson Pharmaceuticals, Changchun High-tech, Eyre Ophthalmology, Pharmaceutical Sining Biology, Zhifei Bio is also among the industry's market value top10 Compared with the beginning of the year, 51 pharmaceutical companies rose in market capitalisation
    of the 59 pharmaceutical and biological companies in the top 500, compared with the beginning of the year, the market value of the rise of the list of 51 companies, only 8 of the decline in the ranking , the ranking swells are: Conchino Bio-B (forward 861), minimally invasive medicine (forward 790), Yingling Pharmaceuticals (forward 583), Opcomvision (forward 411), Renfu Pharmaceuticals (forward 402), and Reding Pharmaceuticals (forward 400)), Huahai Pharmaceuticals (forward 355), Fish Leap Medical (forward 314), Dabo Medical (forward 308), Beida Pharmaceuticals (forward 304), Huada Gene (forward 301), Cinda Bio (forward 290), KaiLaiying (forward 230), etc The market value of 12 pharmaceutical companies has increased by more than 100% the market value of pharmaceutical biological companies have Ali Health, Zhifei Bio, Ping An Good Doctor, Cinda Bio, Huada Gene, Beda Pharmaceuticals, Micro-Invasive Medical, Huahai Pharmaceuticals, Consion Bio-B, Reding Pharmaceuticals, Yiling Pharmaceuticals, Wanfu Bio 12 enterprises Among them, The market value of Consinotle Bio-B grew by 269.83 percent, with a market capitalization of $43.5 billion Micro-Invention Healthcare's market value rose 268.76 percent to $49.5 billion , in addition, Changchun Gaoxin, Kantai Bio and other pharmaceutical and biological companies, the market value of the market also rose by nearly 100% This can also be seen in the pharmaceutical market good situation  Guangdong pharmaceutical enterprises "top list", Shanghai, Beijing, Zhejiang followed closely followed listed enterprises around the situation is to examine the regional pharmaceutical biological strength of an important dimension In terms of regional distribution, there are 11 pharmaceutical and biological companies in Guangdong listed in the top 500 list of listed companies in China, including Meirui Medical, Kantai Bio, Evergrande Health, New Industries, Huada Gene, Jianfan Bio and so on Among them, Meirui Medical ranked 28th among the top 500 companies with a market capitalization of 371.6 billion yuan, and ranked second in the pharmaceutical and biological industry, with a market capitalization of 68.06 percent Jiangsu has nine pharmaceutical companies into the top 500, including Hengrui Pharmaceuticals, Hanson Pharmaceuticals, Pharmaceutical Mingkang, Legendary Biology, Fish Leap Medical, Cinda Bio and so on Among them, Hengrui Pharmaceuticals, Hanson Pharmaceuticals, Pharmaceutical Mingkang ranked in the top 500 list of pharmaceutical bio-industry in the top 10 Shanghai, Beijing and Zhejiang followed Among them, there are 7 in Shanghai into the top 500, including Ping An Good Doctor, Fosun Pharmaceuticals, Shanghai Laishi Guo Pharmaceutical Holdings, Minimally Invasive Medical, Shanghai Pharmaceuticals, etc.; , Hong Kong, Hunan, Yunnan, Fujian, Yunnan, Henan and Tianjin each have 2 pharmaceutical and biological companies into 500, Jilin, Chongqing, Sichuan, Anhui, Hebei, Hubei, 1 pharmaceutical companies each on the list 2020 New Issue of China's Top 500 Market Capitalization List (Pharmaceutical and Biological Industry) based on 21 Data News Labs (statistics as of June 30, 2020)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.